Education

Ph.D. in Molecular Medicine, University of Torino, 2012

Current position

AIRC post-doc fellow, Molecular Biotechnology Center, Department of Molecular Biotechnology and Health Sciences, University of Torino, Italy

Publications

1. Pinatel, E. M., Orso, F., Penna, E., Cimino, D., Elia, A. R., Circosta, P., Dentelli, P., Brizzi, M. F., Provero, P. and Taverna, D. (2014). miR-223 Is a Coordinator of Breast Cancer Progression as Revealed by Bioinformatics Predictions. PLoS One 9(1): e84859.
   
2. Penna, E., Orso, F., Cimino, D., Vercellino, I., Grassi, E., Quaglino, E., Turco, E. and Taverna, D. (2013). miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation. Cancer Res 73(13): 4098-4111.
   
3. Cimino, D., De Pitta, C., Orso, F., Zampini, M., Casara, S., Penna, E., Quaglino, E., Forni, M., Damasco, C., Pinatel, E., Ponzone, R., Romualdi, C., Brisken, C., De Bortoli, M., Biglia, N., Provero, P., Lanfranchi, G. and Taverna, D. (2013). miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1. FASEB J 27(3): 1223-1235.
   
4. Penna, E., Orso, F., Cimino, D., Tenaglia, E., Lembo, A., Quaglino, E., Poliseno, L., Haimovic, A., Osella-Abate, S., De Pitta, C., Pinatel, E., Stadler, M. B., Provero, P., Bernengo, M. G., Osman, I. and Taverna, D. (2011). microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 30(10): 1990-2007.
   
5. Orso, F., Penna, E., Cimino, D., Astanina, E., Maione, F., Valdembri, D., Giraudo, E., Serini, G., Sismondi, P., De Bortoli, M. and Taverna, D. (2008). AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs. FASEB J 22(8): 2702-2714.
   
6. Orso, F., Fassetta, M., Penna, E., Solero, A., De Filippo, K., Sismondi, P., De Bortoli, M. and Taverna, D. (2007). The AP-2alpha transcription factor regulates tumor cell migration and apoptosis. Adv Exp Med Biol 604: 87-95.